Join the Stanford Biotechnology Group (Website:
stanfordbiotechgroup.com; Twitter @stanfordbiotech,
https://twitter.com/stanfordbiotech) on Friday, 4/23, at 12pm PT to learn about how Graphite Bio, a leading gene therapy company, went from Stanford lab to full-fledged startup. We will be sending out the Zoom link the day before the event to those who RSVPed here.
Speakers:
- Dr. Matt Porteus, academic founder, Professor and Co-Director of the Center for Definitive and Curative Medicine at Stanford
- Dr. Josh Lehrer, CEO, former Chief Medical Officer at Global Blood Therapeutics
- Perry Karsen, Chairman, Venture Partner at Samsara BioCapital, former CEO at Celgene Cellular Therapeutics